M-1 Ventures’ accelerator program to provide emerging businesses funding and mentorship
Clinical Study Targeting Prevention of Recurrence of High-Risk Oral Cavity Cancer
Living Pharma is the first UMB New Ventures Initiative start-up to execute a successful exit.
Phase 3-ready program complements Biogen’s ongoing development efforts in stroke
Innovative science at the UMB is getting an extra boost through a program fueled by UM Ventures called the “New Ventures Initiative” (NVI) (headquartered in the Lion Brothers Building)
In an effort to increase commercialization of its leading-edge research and support the growth of promising companies, the University System of Maryland (USM) is launching a new $25M early-stage investment fund, the Maryland...
UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.
Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.
UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.